Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agenus Inc. (AGEN) vs Orchestra BioMed Holdings, Inc. (OBIO)

Agenus Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Agenus Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($375.3M and $366.0M). Orchestra BioMed Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 3.2×. Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 30.5%. Agenus Inc. has the higher net margin (69.2% vs −186.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Agenus Inc. leads on 12 and Orchestra BioMed Holdings, Inc. on 3.

Valuation

Metric AGEN OBIO Biotechnology median
P/E 3.23 n/m 7.88
P/S 2.66 11.87 11.47
P/B n/m 19.65 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 9.48 n/m 0.74
EV/Sales 2.92 9.52 10.73
Earnings yield 30.99% (14.29%) (28.84%)
Free cash flow yield (27.80%) (15.57%) (23.03%)

Profitability

Metric AGEN OBIO Biotechnology median
Gross margin 99.52% 99.51% 65.16%
Operating margin 27.28% (181.36%) 0.00%
Net margin 69.18% (186.30%) 0.00%
Free cash flow margin (73.97%) (184.83%) 0.00%
Return on equity (33.86%) (607.32%) (57.72%)
Return on assets 51.30% (75.16%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AGEN OBIO Biotechnology median
Revenue growth (TTM) 30.47% 986.14% 5.64%
EPS growth (last fiscal year) 100.00% 33.13% —
Revenue growth, 5-year CAGR 5.31% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AGEN OBIO Biotechnology median
Debt to equity (0.15) 1.80 0.00
Current ratio 0.34 8.26 4.73
Net debt to EBITDA (4.10) 1.80 0.96

Dividend

Metric AGEN OBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AGEN OBIO Biotechnology median
Market cap 375.30m 366.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack